Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111718253B reveals a high-yield route for rhodium caprylate dimer, offering cost-effective homogeneous catalysis solutions for pharmaceutical intermediates.
Patent CN108586547B reveals stable nickel catalysts for 1,1-diarylethanes. Offers cost reduction and supply chain reliability for fine chemical intermediates.
Novel semipinacol rearrangement route for high-purity chiral spiro ketones. Efficient scale-up for pharma intermediates and catalyst ligands.
Patent CN113105354B enables catalyst-free synthesis ensuring high purity and cost efficiency for reliable pharmaceutical intermediates supply chains globally.
Patent CN107721969B reveals a safe, high-yield route for chiral TADDOLs using isopropyl magnesium bromide, offering significant cost reduction and supply chain reliability.
Patent CN101440059A details a novel N-oxide route for 4-substituted 2,2'-bipyridines, offering high purity for OLED materials and catalyst ligands with scalable manufacturing.
Advanced ruthenium catalyst technology for cyclic carbonate hydrogenation. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN103502208B reveals mild diamine synthesis avoiding Birch reduction. Enables cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN100425598C details a novel one-step synthesis of chiral oxazolines using Lewis acid catalysts, offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Patent CN117164488B reveals metal-free photocatalysis for high-purity intermediates. Achieve substantial cost reduction and supply chain reliability with scalable green chemistry solutions.
Patent CN110655480A reveals a green Ru/C-catalyzed oxidation method for sulfones. Achieve near-quantitative yields in water, offering significant cost reduction and supply chain reliability.
Patent CN108929345A reveals stable ferrocene ligands for asymmetric hydrogenation. Enhances purity and reduces processing costs for pharmaceutical intermediate manufacturing supply chains.
Novel catalyst-free synthesis patent CN109734691A offers high yield and mild conditions for scalable pharmaceutical intermediate manufacturing and supply chain stability.
Patent CN106588856A enables green synthesis of xanthene diones without catalysts, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel metal-free photocatalytic decarboxylation method for high-purity tetrahydroquinoline intermediates with scalable green chemistry.
Patent CN101270112A details a polymeric Schiff base-metal complex for high-ee cyclic carbonates, offering superior recyclability and cost efficiency for pharma intermediates.
Patent CN113105301A details a novel ortho-carborane copper complex for mild Glaser coupling, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Novel asymmetric Mannich catalyst synthesis via eco-friendly oxygen oxidation. Delivers high ee values for beta-amino carbonyls. Reliable supply chain solution.
Patent CN104119352B reveals manganese-catalyzed asymmetric epoxidation. Delivers high purity chiral epoxides with reduced waste and scalable supply chain reliability for global pharmaceutical intermediates.
Novel iron-catalyzed asymmetric hydrogenation using chiral quinoline imidazoline ligands offers high enantioselectivity and cost-effective alternatives to noble metals for pharmaceutical intermediates.